Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BYCritical Care

Predictive validity of daily sequential organ failure assessment (SOFA)-2 score for 30-day mortality

5 affiliations
  1. 1Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
  2. 2Section of Anaesthesiology and Intensive Care Medicine, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
  3. 3Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden. [email protected]
  4. 4Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care Karolinska Institutet, Karolinska Institutet, 171 77, Stockholm, Sweden. [email protected]
  5. 5Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care Karolinska Institutet, Karolinska Institutet, 171 77, Stockholm, Sweden

Abstract

PURPOSE: The sequential organ failure assessment (SOFA) score was recently updated to better reflect contemporary intensive care. This study compares the predictive validity of the updated SOFA-2 and the previous SOFA-1 for 30-day mortality over the first week in ICU, overall and in subgroups with distinct age and comorbidity profiles. METHODS: We conducted a retrospective observational study of adult patients admitted to four ICUs in Sweden from 2010 to 2021. Predictive validity for 30-day mortality was assessed on day 1-7 using the area under the receiver operating characteristic curve (AUROC). RESULTS: We included 29,820 admissions (mean age 60 years, 64.8% males, median Charlson comorbidity index [CCI] 1). Reclassification between SOFA-1 and SOFA-2 occurred in 75-79% of admissions across days 1-7. On day 1, the AUROC for 30-day mortality was 0.81 (95% CI 0.80-0.81) for SOFA-2 and 0.80 (95% CI 0.79-0.81) for SOFA-1 (p < 0.001). From day 2 onward, AUROCs declined for both scores and were largely similar. Among trauma patients (mean age 50 years; median CCI 0), day-1 AUROC for SOFA-2 was 0.81 (95% CI 0.79-0.83), while among sepsis patients (mean age 61 years; median CCI 3) it was 0.72 (95% CI 0.70-0.74), with comparable performance for SOFA-1. CONCLUSIONS: SOFA-2 provided modestly better discrimination for 30-day mortality on ICU-day 1 compared with SOFA-1. Predictive validity diminished over subsequent days for both scores and varied across subgroups with different age and comorbidity distributions, underscoring the context-dependence of organ dysfunction scoring. TRIAL REGISTRATION: https://doi.org/10.5281/zenodo.17651826 , registration date November 19, 2025.

Related

  1. Discriminatory power of organ-specific Sequential Organ Failure Assessment (SOFA) scores: Predictors of maternal mortality in obstetric intensive care units (ICU)
    Monica Agrawal, Kathipri Nelia, Armin Ahmed +2
    Journal of family medicine and primary carePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  2. Sequential Organ Failure Assessment Score as a Predictor of Intensive Care Unit Mortality in Patients With Maxillofacial Trauma: A Prospective Observational Study.
    Hanish Shashidhar, Prasad P Ingley, Arani Roy +5
    CureusPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. Incremental prognostic value of the T-helper 1/T-helper 2 immune phenotype and 72-h change in sequential organ failure assessment for in-hospital mortality in sepsis with and without type 2 diabetes: a retrospective two-cohort study
    Dongxu Pan, Zongnan Lv, Jiayan Li +5
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
  4. Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure
    Caizhi Dai, Xiaomin Chen, Xiuting Chen +1
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. High-flow nasal cannula versus standard oxygen therapy for adult acute hypoxemic respiratory failure: a systematic review and meta-analysis with trial sequential analysis and GRADE assessment
    Liangdong Zhu, Xun Yang, Jing Tan +1
    BMC Pulmonary MedicinePeer-reviewedCC BYFull textGeneral medicineDOAJ
BibTeX
@article{helleberg2026predictive,
  title = {{Predictive validity of daily sequential organ failure assessment (SOFA)-2 score for 30-day mortality}},
  author = {Johan Helleberg and Anna Sundelin and Navid Soltani and Olav Rooyackers and Johan Mårtensson},
  journal = {Critical Care},
  year = {2026},
  month = jun,
  doi = {10.1186/s13054-026-06093-8},
  url = {https://doi.org/10.1186/s13054-026-06093-8},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Predictive validity of daily sequential organ failure assessment (SOFA)-2 score for 30-day mortality
AU  - Johan Helleberg
AU  - Anna Sundelin
AU  - Navid Soltani
AU  - Olav Rooyackers
AU  - Johan Mårtensson
PY  - 2026
DA  - 2026/06/01
JO  - Critical Care
DO  - 10.1186/s13054-026-06093-8
UR  - https://doi.org/10.1186/s13054-026-06093-8
AB  - PURPOSE: The sequential organ failure assessment (SOFA) score was recently updated to better reflect contemporary intensive care. This study compares the predictive validity of the updated SOFA-2 and the previous SOFA-1 for 30-day mortality over the first week in ICU, overall and in subgroups with distinct age and comorbidity profiles. METHODS: We conducted a retrospective observational study of adult patients admitted to four ICUs in Sweden from 2010 to 2021. Predictive validity for 30-day mortality was assessed on day 1-7 using the area under the receiver operating characteristic curve (AUROC). RESULTS: We included 29,820 admissions (mean age 60 years, 64.8% males, median Charlson comorbidity index [CCI] 1). Reclassification between SOFA-1 and SOFA-2 occurred in 75-79% of admissions across days 1-7. On day 1, the AUROC for 30-day mortality was 0.81 (95% CI 0.80-0.81) for SOFA-2 and 0.80 (95% CI 0.79-0.81) for SOFA-1 (p < 0.001). From day 2 onward, AUROCs declined for both scores and were largely similar. Among trauma patients (mean age 50 years; median CCI 0), day-1 AUROC for SOFA-2 was 0.81 (95% CI 0.79-0.83), while among sepsis patients (mean age 61 years; median CCI 3) it was 0.72 (95% CI 0.70-0.74), with comparable performance for SOFA-1. CONCLUSIONS: SOFA-2 provided modestly better discrimination for 30-day mortality on ICU-day 1 compared with SOFA-1. Predictive validity diminished over subsequent days for both scores and varied across subgroups with different age and comorbidity distributions, underscoring the context-dependence of organ dysfunction scoring. TRIAL REGISTRATION: https://doi.org/10.5281/zenodo.17651826 , registration date November 19, 2025.
SN  - 1364-8535
SN  - 1466-609X
SN  - 1574-4280
SN  - 1875-7081
ER  -